Title of article :
Updates in the Management of Gout
Author/Authors :
Michael P. Keith، نويسنده , , William R. Gilliland، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2007
Abstract :
The majority of patients with gout are cared for by primary care physicians. Although both the physician and patient may easily recognize the acute arthritis of gout, errors in selecting the most appropriate medication and proper dose are common. The clinical stages of gout include asymptomatic hyperuricemia, intermittent gouty arthritis, and chronic tophaceous gout. Treatment of gout is usually considered after the first attack of arthritis, typically podagra. The aims of treatment are to alleviate the pain and inflammation associated with acute attacks, prevent future attacks, and decrease uric acid levels. Confusion frequently arises because certain medications such as colchicine may have dual purposes: to treat an acute attack and to suppress future attacks. The purpose of this management update is to provide practical advice about prescribing the proper medication considering both treatment goals and patient comorbidities.
Keywords :
Gout , Management , Colchicine , Nonsteroidal anti-inflammatory agents , Xanthine oxidase , probenecid , Febuxostat
Journal title :
The American Journal of Medicine
Journal title :
The American Journal of Medicine